by rdbiomed | Feb 5, 2021 | GERD, health, LPR
People with problems in the upper gastrointestinal (GI) tract may be vulnerable to infection after ‘swallowing’ the Covid-19 virus, a new study has suggested. Researchers at the Washington University School of Medicine found that patients with Barrett’s... 
by rdbiomed | Jan 23, 2020 | LPR
A new UK study with more than 1,000 patients has demonstrated how Peptest can be used to diagnose laryngopharyngeal reflux (LPR) in hospitals, voice clinics and GP surgeries. LPR is a condition responsible for up to 10 per cent of all otolaryngology (ear, nose and... 
by rdbiomed | Nov 11, 2019 | Company Updates, LPR
Peptest has been described as a ‘cost‐effective, non-invasive measurement tool’ to assist office‐based diagnosis of laryngopharangeal reflux disease (LPR) in a new research paper. The study, published in The Laryngoscope – the monthly peer-reviewed medical... 
by rdbiomed | Sep 17, 2019 | LPR
Information on a UK multicentre study evaluating the use of Peptest for patients with laryngopharyngeal reflux (LPR) will be presented at a world-class laryngology conference this month. The Cutting Edge Laryngology Conference showcases the most up-to-date advances in... 
by rdbiomed | Jun 17, 2019 | LPR, pepsin
Peptest can be used to diagnose Extraoesophageal reflux (EER) – especially in children with chronic otitis media with effusion (OME) – a professor has highlighted in a recently published paper. OME – often dubbed ‘glue ear’ – occurs frequently in younger... 
by rdbiomed | Jun 10, 2019 | Company Updates, LPR
Peptest has been cited in a new book that focusses on the diagnosis and management of specific benign diseases of the foregut, including reflux disease. The foregut comprises the mouth, oesophagus and the cardiac and pyloric regions of the stomach. Written by experts...
Recent Comments